Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 30, 2022 - Issue 3
Submit an article Journal homepage
289
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Does Pharmaceutical Compounding of Vascular Endothelial Growth Factor Inhibitors for Intravitreal Use Alter the Risk of Post-injection Endophthalmitis?

Kathrine Bloma Department of Ophthalmology, Oslo University Hospital, Oslo, NorwayCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3630-2241
, MDORCID Icon,
Ragnheiður Bragadóttira Department of Ophthalmology, Oslo University Hospital, Oslo, Norway;b Faculty of Medicine, University of Oslo, Oslo, Norway
, MD, PhD,
Magne Sand Sivertsena Department of Ophthalmology, Oslo University Hospital, Oslo, Norway
, MD, PhD,
Morten Carstens Moea Department of Ophthalmology, Oslo University Hospital, Oslo, Norway;b Faculty of Medicine, University of Oslo, Oslo, Norway
, MD, PhD &
Øystein Kalsnes Jørstada Department of Ophthalmology, Oslo University Hospital, Oslo, Norway;b Faculty of Medicine, University of Oslo, Oslo, NorwayORCID Iconhttps://orcid.org/0000-0003-1259-0653
, MD, PhDORCID Icon
Pages 713-716 | Received 29 Apr 2020, Accepted 03 Sep 2020, Published online: 07 Oct 2020

References

  • Goldberg RA, Flynn HW Jr., Miller D, et al. Streptococcus endophthalmitis outbreak after intravitreal injection of bevacizumab: one-year outcomes and investigative results. Ophthalmology. 2013;120(7):1448–1453. doi:10.1016/j.ophtha.2012.12.009. [published Online First: 2013/03/05].
  • Khan P, Khan L, Mondal P. Cluster endophthalmitis following multiple intravitreal bevacizumab injections from a single use vial. Indian J Ophthalmol. 2016;64(9):694–696. doi:10.4103/0301-4738.99855. [published Online First: 2016/11/18].
  • Gonzalez S, Rosenfeld PJ, Stewart MW, et al. Avastin Doesn’t Blind People, People Blind People. Am J Ophthalmol. 2012;153(2):196–203.e1. doi:10.1016/j.ajo.2011.11.023. [published Online First: 2012/01/24].
  • Bavinger JC, Yu Y, VanderBeek BL. COMPARATIVE RISK OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION WITH BEVACIZUMAB, AFLIBERCEPT, AND RANIBIZUMAB. Retina. 2018. doi:10.1097/iae.0000000000002351. [published Online First: 2018/10/13].
  • Avery RL, Bakri SJ, Blumenkranz MS, et al. Intravitreal injection technique and monitoring: updated guidelines of an expert panel. Retina. 2014;34(Suppl 12):S1–S18. doi:10.1097/IAE.0000000000000399. [published Online First: 2014/12/10].
  • Sivertsen MS, Jorstad ØK, Grevys A, et al. Pharmaceutical compounding of aflibercept in prefilled syringes does not affect structural integrity, stability or VEGF and Fc binding properties. Sci Rep. 2018;8(1):2101. doi:10.1038/s41598-018-20525-8. [published Online First: 2018/02/03].
  • Blom K, Jorstad ØK, Bragadottir R. Endophthalmitis in Oslo, Norway. Acta Ophthalmol. 2019;97(7):695–699. doi:10.1111/aos.14028. [published Online First: 2019/03/01].
  • Hujanen P, Tuulonen A, Uusitalo‐Järvinen H. Real-world efficacy and safety of dividing aflibercept into three syringes in the treatment of wet age-related macular degeneration. Acta Ophthalmol. 2019;97(5):e812–e13. doi:10.1111/aos.14051. [published Online First: 2019/02/15].
  • Baudin F, Benzenine E, Mariet A-S, et al. Association of acute endophthalmitis with intravitreal injections of corticosteroids or anti-vascular growth factor agents in a nationwide study in France. JAMA Ophthalmol. 2018;136(12):1352–1358. doi:10.1001/jamaophthalmol.2018.3939.
  • Mishra C, Lalitha P, Rameshkumar G, et al. Incidence of endophthalmitis after intravitreal injections: risk factors, microbiology profile, and clinical outcomes. Ocul Immunol Inflamm. 2018;26(4):559–568. doi:10.1080/09273948.2018.1430238. [published Online First: 2018/02/14].
  • VanderBeek BL, Bonaffini SG, Ma L. Association of compounded bevacizumab with postinjection endophthalmitis. JAMA Ophthalmology. 2015;133(10):1159–1164. doi:10.1001/jamaophthalmol.2015.2556. [published Online First: 2015/ 08/14].
  • Helsedirektoratet. Infeksjon etter injeksjon i øyet 2017 Available from: https://www.google.no/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=2ahUKEwiA85Ha0LTkAhXDpYsKHUynDLkQFjAAegQIABAC&url=https%3A%2F%2Fwww.helsedirektoratet.no%2Flaeringsnotat%2Finfeksjon-etter-injeksjon-i-oyet%2FInfeksjon%2520etter%2520injeksjon%2520i%2520%25C3%25B8yet.pdf&usg=AOvVaw187e2LDIovdmJQA-e8I-nt (accessed 03.09.2019)
  • Relhan N, Forster RK, Flynn HW Jr. Endophthalmitis: then and Now. Am J Ophthalmol. 2018;187:xx–xxvii. doi:10.1016/j.ajo.2017.11.021. [published Online First: 2017/12/09].
  • Mahabadi N, Ngando IA, Czyz CN. Bacterial Endophthalmitis. StatPearls. Treasure Island (FL): StatPearls Publishing. StatPearls Publishing LLC; 2019.
  • Kiss S, Dugel PU, Khanani AM, et al. Endophthalmitis rates among patients receiving intravitreal anti-VEGF injections: a USA claims analysis. Clin Ophthalmol. 2018;12:1625–1635. doi:10.2147/opth.S169143. [published Online First: 2018/09/15].
  • VanderBeek BL, Bonaffini SG, Ma L. The Association between Intravitreal Steroids and Post-Injection Endophthalmitis Rates. Ophthalmology. 2015;122(11):2311–15.e1. doi:10.1016/j.ophtha.2015.07.005. [published Online First: 2015/08/19].
  • Williams PD, Chong D, Fuller T, et al. Noninfectious vitritis after intravitreal injection of anti-vegf agents: variations in rates and presentation by medication. Retina. 2016;36(5):909–913. doi:10.1097/iae.0000000000000801. [published Online First: 2016/04/27].
  • Daien V, Nguyen V, Essex RW, et al. Incidence and outcomes of infectious and noninfectious endophthalmitis after intravitreal injections for age-related macular degeneration. Ophthalmology. 2018;125(1):66–74. doi:10.1016/j.ophtha.2017.07.005. [published Online First: 2017/08/13].
  • Fileta JB, Scott IU, Flynn HW Jr. Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmic Surg Lasers Imaging Retina. 2014;45(2):143–149. doi:10.3928/23258160-20140306-08. [published Online First: 2014/03/19].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.